Infection risk with anti-TNFs early in IBD


Serious infection risk in people with inflammatory bowel disease treated with anti-TNFs is increased mainly at the start of treatment, a large national registry study shows. The study of 52 392 people with inflammatory bowel disease (IBD) found a statistically significant 63% increased risk of serious infections in people treated with  TNF-α inhibitors within 90 days ...


Already a member? Login to keep reading


OR
© 2017 the limbic